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Objectives: To study thrombin and plasmin activation during elective abdominal aortic aneurysm surgery. 
Design: Prospective study. 
Setting: University Hospital. 
Materials: Nine consecutive patients undergoing elective surgery were included. The mean age was 72 years (range 
60-79). Blood samples were drawn: (1) before induction of anaesthesia; (2) after induction and Swan Ganz catherisation; 
(3) just before cross-clamping; (4) before &clamping; (5) 8 h postoperatively; (6) 18 h postoperatively. 
Chief outcome measures" Assays included: prothrombin time (PT), activated partial thromboplastin time (APTT), 
fibrinogen, prothrombin fragments (F 1 + 2), anti-thrombin III (ATIII), plasminogen, a2-antiplasmin, haematocrit, 
platelet and serum protein for correction of haemodilution. Data were expressed as mean (s.D.). Differences between mean 
values were tested by means of the ANOVA for repeated measures and the Wilcoxon signed rank test. 
Main results: The APTT and TT did not change until heparinisation. The F 1 + 2 were already elevated preoperatively. 
After correction for haemodilution the AT III and a2-antiplasmin decreased in time (p = 0.009 and 0.0023, respectively) 
and the F1 + 2 increased (p < 0.0001). Postoperatively (t5 and 6) the values normalised again. 
Conclusions: The coagulation and fibrinolytic systems are activated uring and after elective aortic replacement. Standard 
tests, like the prothrombin and partial thromboplastin time, are unreliable when assessing the coagulation status of the 
patient. 
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Introduction 
Aortic grafting for abdominal aortic aneurysm ay be 
accompanied by major peroperative blood loss. Even 
after a surgical cause of bleeding has been eliminated 
a disturbance of the balance between coagulation and 
fibrinolysis may have developed causing a coagulop- 
athy which can lead to generalised oozing and severe 
blood loss. It has been shown that perioperative 
coagulopathy in patients with a ruptured abdominal 
aortic aneurysm is a strong indicator of poor out- 
come. ~'2 It is well known that the aneurysm itself can 
be the cause of clotting disorders, like intravascular 
coagulation 3-9 which occurs in up to 4% of patients9 
However, it is unknown whether other perioperative 
features contribute to coagulopathy. Besides adequate 
haemostasis, another major issue is adequate tissue 
perfusion. The circulation may be supported by 
infusion of fluids. Epidural analgaesia causes vasodi- 
lation necessitating volume replacement. All together 
these measures will lead to haemodilution, which may 
have an impact on the level and activity of coagulation 
and fibrinolytis factors. 
The aim of this study was to determine whether, 
and when, thrombin and/or plasmin activation takes 
place in patients operated on for an abdominal aortic 
aneurysm. The impact of volume loading on the level 
and activity of clotting factors was also investigated. 
Patients and Methods 
Nine consecutive patients undergoing elective repair 
of infrarenal aortic aneurysms were included. The 
mean age was 72 years (range 60-79) and in all 
patients a preclotted tube or bifurcation graft of 
knitted Dacron was inserted. 
A standardised anaesthetic procedure was per- 
formed. Patient were positioned on a heated mattress. 
Induction was performed with 0.0ling sufentanil 
forte, 0.1 mg pancuronium, 0.2 mg etomidate and i mg 
dexamethason all per kg of body weight. During 
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induction of anaesthesia volume loading with NaC1 
0.9% was performed at a rate of 10-20ml/kg/h.  
Before cross-clamping patients were heparinised with 
5000 IU of heparin. Anaesthesia was maintained with 
sufentanyl forte and midazolam. When necessary 
dopamine and nitroglycerine were added. Blood loss 
was compensated by NaC1 0.9%, autologous transfu- 
sion by use of the cell saver and units of homologous 
packed cells. Postoperatively patients were artificially 
ventilated until their circulatory and respiratory con- 
dition were stable. ., 
Blood samples were ast~irated from the radial artery 
on the following time (t) points: (1) before induction of 
anaesthesia; (2) after induction of anaesthesia nd 
Swan Ganz catherisatiorii (3) during the operation 
before cross-clamping; (4)'after insertion of the pros- 
thesis and before declamp!ng; (5) 8 h postoperatively; 
(6) 18 h postoperatively. Blood was drawn into plastic 
syringes and immediately transferred into 0.106 
retool/1 trisodium citrate, Platelet poor plasma was 
prepared by centrifugation at 2000g for 10 min and 
made platelet-free by a second centrifugation step 
(12000 r.p.m, for 3 rain inan  Eppendorf centrifuge). 
The prothrombin time (PT) and activated partial 
thromboplastin time (NPTT) were automatically 
assayed, using Thromborel (Behringwerke, Marburg, 
Germany) and PTT (Boehringer, Mannheim, Ger- 
many), respectively. The l fibrinogen level was deter- 
mined using the method 0f Clauss. Antithrombin III 
was assayed with the chromogenic substrate S-2765 
(Chromogenix, Molndal,~Sweden). Plasminogen was 
determined using S-2403 (Chromogenix) and a2-anti- 
plasmin using S 2251 (Chromogenix). Prothrombin 
fragment 1 + 2 was assayed by an ELISA technique 
(Enzygnost, Behringwerke, Germany). Al l  tests were 
performed according the guidelines of the 
manufacturers. 
Blood was also transferred into EDTA prefilled 
tubes for conventional estimation of haematocrit and 
platelet count (Table 1). The serum total protein 
concentration (TP: g/l) was determined to permit a 
correction for haemodilution, by dividing the clotting 
parameters by this value. These corrected values for 
the haemostatic parameters are indicated as index 
numbers. For every time point the mean (S.D.) of the 
parameters was calculated. Differences between mean 
values were analysed by the ANOVA for repeated 
measures (BMDP version 7.0) and the Wilcoxon 
signed rank test. Alp-value of less than 0.05 was 
considered statistically significant. 
Results 
The mean peroperative blood loss was 2500 ml (range 
1100-9500ml). In eight patients there was no major 
surgical bleeding and all patients remained stable 
perioperatively. The mean aortic cross-clamping time 
was 80 rain (range 30-150). 
The mean total protein concentration was initially 
56g/1 (tl), and decreased by 34% to 37g/1 at t4 as a 
Table 1. Routine laboratory tests and parameters of thrombin and plasmin formation during and after abdominal aortic aneurysm 
replacement. Values are given as mean (S.D.). For time points see materials and methods. 
Time points 
,.i 
Parameters 1 .,~ 2 3 4 5 6 Normal value 
Haematocrit 0.45 0.36 0.31 0.29 0.33 0.33 0.40~.501/1 
(0.06) (0.03) (0.03) (0.06) (0.06) (0.06) 
Platelet 213 190 158 128 134 126 200-300 x1091 
(88) (88) (67) (49) (66) (74) 
Total protein 56 50 43 37 48 48 40~0 g/1 
(8) (6) (5) (4) (5) (5) 
PT i7 16 19 25 18 17 16_+2 s 
(3) (2) (3) (3) (1) (2) 
APTT 49 46 56 116 44 40 25-35 s 
(9) (10) (26) (11) (7) (5) 
Fibrinogen 3.4 3.5 2.9 2.2 2.1 2.9 24 g/1 
(L6) (1.3) (1.4) (1.0) (0.7) (0.8) 
AT III 85 83 65 41 67 78 >80% 
(25)' (22) (14) (6) (29) (19) 
F 1 + 2 2.3 1.7 2.5 1.9 3.3 2:0 0.4-1.1 nnmol/1 
(1.4) (0.8) (1.7) (1.1) (1.5) (i.0) 
Plasminogen 90 85 75 46 68 62 >70% 
(29) (22) (27) (17) (32) (20) 
a2 antiplasmin 83 85 66 48 61 75 >70% 
(17) (18) (17) (15) (16) (20) 
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result of volume loading (tl-3) and blood loss (t2-4). 
The results of laboratory tests are shown in Table 1. 
The haematocrit and platelet count decreased (36% 
and 40% respectively) perioperatively. The APTT and 
PT were elevated at t4 due to routine use of heparin. 
The differences in these values during tl-3 were not 
statistically significant in contrast o the decrease in 
HT, platelet and TP. However, when the decrease in 
platelet was corrected for haemodilution, (Thr/TP) 
there remained a slight, but statistically insignificant 
decrease. When corrected for haemodilution the APTT 
and PT showed a slight, but insignificant increase 
between it and 3. However, these tests were of little 
use due to heparinisation of the patients. 
Plasmin formation was estimated by changes in the 
level of plasminogen. This value decreased during the 
operation, however this decrease was not statistically 
significant for repeated measures (Fig. 1). Thrombin 
formation was estimated by changes in fibrinogen and 
AT III level and especially by changes in the level of 
prothrombin fragment 1 + 2. F 1 + 2 levels were 
increased at the start of the operation and increased 
during and after the operation. However when cor- 
rected for haemodilution there was a highly sig- 
nificant increase perioperatively and a significant 
decrease one day after the operation (Fig. 2). The 
decrease in AT III was also statistically significant. 
(Fig. 3). 
Figures 1-5 show the different parameters of throm- 
bin and plasmin activation, corrected for haemodilu- 
tion (index number). Most values show a slight, but 
insignificant, increase between tl and t2. Five patients 
showed a decreased fibrinogen level at the end of the 
operation, which fell by one-third of the initial level. 
However this decrease was not statistically 
significant. 
0 1 2 
Fig. 1. P lasminogen activity index p = 0.18 (ANOVA). 
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Fig. 2. F 1 + 2 concentration i dex p = 0.0000 (ANOVA); increase t l - t5 p < 0.01, decrease t5-t6 p < 0.01 (Wilcoxon). 
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Fig. 3. Antithrombin III activity index p = 0.009 (ANOVA); decrease tl-t4 p < 0.05, increase t4-t6 p < 0.02 (Wilcoxon). 
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Fig. 4. Fibrinogen index p = 0.11 (ANOVA). 
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Fig. 5. a2 antiplasmin activity index p = 0.0023 (ANOVA); decrease t2-t5 p < 0.05 (Wilcoxon). 
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Discussion 
This study shows that replacement of an abdominal 
aortic aneurysm by a prosthesis is accompanied by 
activation of coagulation and fibrinolytic factors. 
Haemodilution, due to volume therapy, especially 
after declamping, influences the concentration of 
several components of the blood. The haematocrit, 
platelet and total protein concentration decreased 
during the operation as a result of haemodilution, as 
well as blood loss. 
The APTT and PT did not change significantly 
during the operation except during cross-clamping 
(t4), because the patients were heparinised. The 
concentrations of fibrinogen, ATIII, plasminogen and 
c~2 antiplasmin decreased uring the operation and 
the concentration of F1 + 2 increased. These findings 
suggest both thrombin- and plasmin activation. How- 
ever, they should be correlated with the dilution 
factor. After 18 h the parameters returned to their 
preoperative l vel except for plasminogen. In accor- 
dance with the literature, we showed a decrease in the 
levels of some haemostasis factors during the opera- 
tion. 11'12 However, in contrast to our study, these 
studies did not correct for haemodilution, precluding 
the estimation of the impact of thrombin and plasmin 
generation. When the parameters are corrected for 
haemodilution, by dividing the value by the total 
protein concentration, the real consumption and gen- 
eration of thrombin and plasmin activation can be 
calculated (= index number). 
There was a relative decrease of the platelet index 
from a mean of 3.9 to 2.7. Decrease of platelets before 
aortic operations i  well known and is especially seen 
1 in patients with ruptured aneurysm. Platelet function 
13 is also decreased. It has been shown that ulcerated 
plaques are responsible for platelet aggregation. 14
Decrease of platelet count (< 100 × 109/1), combined 
with an increase in coagulation time is associated with 
a high mortality rate of 65-70%. ~'2 The syndrome of 
intravascular coagulation (consumption coagulop- 
athy) has been described in patients with an aortic 
aneurysm, s'8'15 This entity is characterised by a low 
platelet count, low fibrinogen level, elevated fibrin 
degradation products (FDP) and prolongation of one 
or more coagulation function tests. 15 Our patients 
showed an overall increased F 1 + 2 level preopera- 
tively, suggesting that there was a low level of 
thrombin activation preoperatively. We did not meas- 
ure FDP in our patients, because the level of FDP is 
influenced by many factors not relevant for this study. 
Three patients in our series had a decreased fibrinogen 
level (< 2 g/l) preoperatively (tl) while other criteria 
of intravascular coagulation were absent. Five patients 
had decreased fibrinogen levels perioperatively (t4). 
When the correction for haemodilution was calculated 
the mean loss of fibrinogen was one-third of its initial 
level. 
The thrombin activation system was induced: the 
ATIII index decreasing from a mean of 1.55 to 1.10 
from tl to t4. Whether this decrease was completely 
due to heparin (ATIII binding) remains to be 
resolved.16'17The mean decrease in our patients was 
25% within a few hours. In the literature a decrease of 
30% has been reported after 3-5 days of continuous 
infusion of heparin, is There is at least a non-heparin 
induced effect during the operation. The index of F 
1 + 2 increased from 41 to 64 perioperatively, indicat- 
ing thrombin activation. At t6 this level had only 
normalised in three patients ( < 1.1 nmol/1). However 
the mean value had returned to the preoperative l vel. 
It should be noted that the increase of F 1 + 2 had 
already started at t3 after the insertion of the Swan 
Ganz catheter, which may be a causative factor. As a 
result of an activated coagulation cascade, the fibrino- 
lytic cascade is also activated. Plasmin, split from 
plasminogen, decreased perioperatively. The concen- 
tration index of R2 antiplasmin is decreased from 1.7 
at, period 2 to 1.2 at period 5. In contrast to the 
plasminogen level which remained low, the level of 
this inhibitor increased again to preoperative values. 
This could be due to rapid synthesis of this protein or 
is it an early indicator of normalisation of 
haemostasis? 
Haemostasis can be disturbed by several factors. It 
is proven that the aneurysm itself can be the cause due 
to local consumption, s'15 However it is likely that the 
inserted prosthesis and other intravenous devices, like 
the Swan Ganz, can also cause an induction of the 
coagulation and fibrinolytic cascade. Reperfusion of 
the intestines and lower extremities may contribute to 
fibrinolysis, while it has been shown that endotoxin 
and interleukin I, which are released by ischaemic 
intestine during cross-clamping, can interfere with the 
endothelial cell function resulting in induction of 
coagulation and fibrinolysis. 19'2° Colon ischaemia dur- 
ing the operation can result in intravascular coagula- 
tion. 21 Hypoxia combined with reperfusion induces 
procoagulant activity. 22 
Haemodilution caused an overall decrease in the 
coagulation and fibrinolysis factors of 50%. However, 
activation of the thrombin and plasmin cascade 
resulted in a loss of 25% of the initial activity, but the 
levels normalised again. The synthesis of coagulation 
factors was not taken into account in our study. About 
10% of the platelet count is produced within 1 day and 
proteins can be synthesised within 8 h. So if we make 
a correction for new formation and synthesis of 
Eur J Vasc Endovasc Surg Vol 13, January 1997 
Haemostasis during Aortic Surgery 65 
clotting parameters, the peroperative decrease would 
be even more significant. Even with a normal APPT 
and PT, diffuse oozing from the retroperitoneum and 
the wound are frequently observed, probably because 
subtle parameters of the coagulation system are 
disturbed. Disturbance in the fibrinolytic system is 
especially difficult to assess. Therefore it may be 
reasonable to influence the fibrinolytic system by 
medication. It has already been shown that aprotinin 
has a beneficial effect on the amount of blood loss by 
antagonising fibrinolysis, z3-25 
In conclusion, in patients undergoing repair of an 
abdominal aortic aneurysm, coagulation and fibrino- 
lytic systems are activated during and after elective 
aortic replacement. Several factors are disturbed due 
to haemodilution, consumption and activation. Stan- 
dard tests like the PT and APTT time are unreliable 
when assessing the coagulation status of the patient. 
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